Tight glycaemic control: clinical implementation of protocols

Best Practice & Research. Clinical Anaesthesiology
Frank NobelsLuc Foubert

Abstract

Implementation of tight glycaemic control in hospitalised patients presents a huge challenge. It concerns many patients, there are many interfering factors and many health-care professionals are involved. The current literature provides little practical guidance. This article offers the clinical anesthesiologist direction for the organisation of inpatient blood glucose control in acute situations, in the perioperative setting and in the intensive care unit. An effective, safe and user-friendly algorithm for intravenous insulin administration is presented that can be executed by regular nurses and used in many situations. Practical advice is offered for the use of subcutaneous basal-bolus insulin, for fasting orders and for transition to discharge care. The main safety considerations are discussed.

References

Jul 5, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·M DaviesJ R Peters
Jan 17, 2002·The New England Journal of Medicine·G van den BergheR Bouillon
Apr 10, 2002·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Lawrence J MarkovitzSusan S Braithwaite
May 29, 2003·The Journal of Thoracic and Cardiovascular Surgery·Anthony P FurnaryAlbert Starr
Jun 6, 2003·The Journal of Clinical Endocrinology and Metabolism·Dace L TrenceIrl B Hirsch
Jan 30, 2004·Diabetes Care·Stephen ClementUNKNOWN American Diabetes Association Diabetes in Hospitals Writing Committee
Apr 6, 2004·Critical Care Medicine·Douglas B CoursinJonathan T Ketzler
Jul 15, 2004·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Bruce W BodePaul C Davidson
Jul 15, 2004·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Susan S BraithwaiteHetal P Mehrotra
Dec 1, 2004·Diabetic Medicine : a Journal of the British Diabetic Association·F NobelsP Van Crombrugge
Jan 14, 2005·The New England Journal of Medicine·Irl B Hirsch
Dec 15, 2005·Critical Care Medicine·Salmaan KanjiPaul C Hebert
Dec 24, 2005·Critical Care Medicine·Titia M VriesendorpJoost B L Hoekstra
Feb 3, 2006·The New England Journal of Medicine·Greet Van den BergheRoger Bouillon
Oct 14, 2006·Diabetes Technology & Therapeutics·Philip A GoldbergSilvio E Inzucchi
Nov 3, 2006·The New England Journal of Medicine·Silvio E Inzucchi
Jan 16, 2007·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Guillermo Umpierrez, Gregory Maynard
Aug 9, 2007·Journal of Hospital Medicine : an Official Publication of the Society of Hospital Medicine·Curtiss B CookRichard S Zimmerman
Jan 11, 2008·The New England Journal of Medicine·Frank M BrunkhorstUNKNOWN German Competence Network Sepsis (SepNet)
Jul 19, 2008·Anesthesia and Analgesia·Patrick LecomteGuy Cammu
Nov 26, 2008·Clinical Chemistry·Mitchell G ScottDavid B Sacks
Dec 6, 2008·Critical Care : the Official Journal of the Critical Care Forum·Patrick LecomteLuc Foubert
Feb 6, 2009·Anesthesiology·Angela K M Lipshutz, Michael A Gropper
Feb 10, 2009·Current Opinion in Clinical Nutrition and Metabolic Care·Kerstin D RöhmSwen N Piper
Mar 26, 2009·The New England Journal of Medicine·Simon FinferJuan J Ronco

❮ Previous
Next ❯

Citations

Oct 31, 2012·Annales Françaises D'anesthèsie Et De Rèanimation·J-V SchaalS Mérat
Jan 31, 2021·The Lancet. Diabetes & Endocrinology·Francisco J PasquelGuillermo E Umpierrez

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.